Pediatric respiratory infections by Mycoplasma pneumoniae

References

• Broughton RA. Infections due to Mycoplasma pneumoniae in childhood. Pediatr. Infect. Dis. J.5(1), 71–85 (1986).
   Web of Science ®Google Scholar
• Ferwerda A, Moll HA, de Groot R. Respiratory tract infections by Mycoplasma pneumoniae in children: a review of diagnostic and therapeutic measures. Eur. J. Pediatr.160(8), 483–491 (2001).
   PubMed Web of Science ®Google Scholar
• Waites KB, Talkington DE. Mycoplasma pneumoniae and its role as a human pathogen. Clin. Microbiol. Rev.17(4), 697–728 (2004).
   PubMed Web of Science ®Google Scholar
• Marston BJ, Plouffe JF, File TM Jr et al. Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch. Intern. Med.157(15), 1709–1718 (1997).
   PubMed Web of Science ®Google Scholar
• Ngeow YF, Suwanjuta S, Chantarojanasriri T et al. An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia. Int. J. Infect. Dis.9(3), 144–153 (2005).
   PubMed Web of Science ®Google Scholar
• Michelow IC, Olsen K, Lozano J et al. Epidemiology and clinical characteristics of community acquired pneumonia in hospitalized children. Pediatrics113(4), 701–707 (2004).
   PubMed Web of Science ®Google Scholar
• Korppi M, Heinskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serologic results of a prospective, population based study in primary health care. Respirology9(1), 109–114 (2004).
   PubMed Web of Science ®Google Scholar
• Chiang WC, Teoh OH, Chong CY, Goh A, Tang JP, Chay OM. Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore. Respirology12(2), 254–261 (2007).
   PubMed Web of Science ®Google Scholar
• Holt PG, Jones CA. The development of the immune system during pregnancy and early life. Allergy55(8), 688–697 (2000).
   PubMed Web of Science ®Google Scholar
• Lee KY, Lee HS, Hong JH et al. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children. Pediatr. Pulmonol.41(3), 263–268 (2006).
   PubMed Web of Science ®Google Scholar
• Lee KY, Lee HS, Hong JH et al. Author reply. Pediatr. Pulmonol.41(10), 1010 (2006).
   Web of Science ®Google Scholar
• Lee SH, Noh SM, Lee KY et al. Clinico–epidemiologic study of Mycoplasma pneumonia pneumonia (1993 through 2003). J. Korean Pediatr.48(2), 154–157 (2005).
   Google Scholar
• Chan ED, Welsh CH. Fulminant Mycoplasma pneumoniae pneumonia. West. J. Med.162(2), 133–142 (1995).
   PubMedGoogle Scholar
• Razin S, Yogev D, Naot Y. Molecular biology and pathogenesity of mycoplasmas. Microbiol. Mol. Biol. Rev.62(4), 1094–1156 (1998).
   PubMed Web of Science ®Google Scholar
• Rottem S. Interaction of mycoplasma with host cells. Physiol. Rev.83(20) 417–432 (2003).
   PubMed Web of Science ®Google Scholar
• Eaton MD, Meiklejohn G, van Herick W. Studies on the etiology of primary atypical pneumonia. A filterable agent transmissible to cotton rats, hamsters, and chick embryos. J. Exp. Med.79, 649–668 (1944).
   PubMedGoogle Scholar
• Chanock RM, Hayflick L, Barile MF. Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO. Proc. Natl Acad. Sci. USA48, 41–49 (1962).
   PubMed Web of Science ®Google Scholar
• Himmelreich R, Hilbert H, Plagens H, Pirkl E, Li BC, Herrmann R. Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae. Nucleic Acids Res.24(22), 4420–4449 (1996).
   PubMed Web of Science ®Google Scholar
• Dandekar T, Huynen M, Regula JT et al. Re-annotating the Mycoplasma pneumoniae genome sequence: adding value, function and reading frames. Nucleic Acids Res.28(17), 3278–3288 (2000).
   PubMed Web of Science ®Google Scholar
• Dallo SF, Baseman JB. Intracellular DNA replication and long-term survival of pathogenic mycoplasmas. Microb. Pathog.29(5), 301–309 (2000).
   PubMed Web of Science ®Google Scholar
• Guarner F, Malagelada JR. Gut flora in health and disease. Lancet361(9356), 512–519 (2003).
   PubMed Web of Science ®Google Scholar
• Acheson DW, Luccioli S. Microbial-gut interactions in health and disease. Mucosal immune response. Best Pract. Res. Clin. Gastroenterol.18(2), 387–404 (2004).
   PubMed Web of Science ®Google Scholar
• Husebye E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy51(Suppl. 1), 1–22 (2005).
   PubMed Web of Science ®Google Scholar
• Hull MW, Chow AW. Indigenous microflora and innate immunity of the head and neck. Infect. Dis. Clin. North Am.21(2), 265–282 (2007).
   PubMed Web of Science ®Google Scholar
• Noah ND. Mycoplasma infection in the United Kingdom: 1967–73. Br. Med. J.2(5918), 544–546 (1974).
   PubMedGoogle Scholar
• Foy HM, Kenny GE, Cooney MK, Allan ID. Long-term epidemiology of infections with Mycoplasma pneumoniae. J. Infect. Dis.139(6), 681–687 (1979).
   PubMed Web of Science ®Google Scholar
• Pönkä A. Occurrence of serologically verified Mycoplasma pneumoniae infections in Finland and in the Scandinavia in 1970–1977. Scan. J. Infect. Dis.12(1), 27–31 (1980).
   PubMedGoogle Scholar
• Lind K, Benzon MW, Jensen JS, Clyde WA Jr. A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946–1995. Eur. J. Epidemiol.13(5), 581–586 (1997).
   PubMed Web of Science ®Google Scholar
• Rastawicki W, Kaluzewski S, Jagielski M. Occurrence of serologically verified Mycoplasma pneumoniae infections in Poland in 1970–1995. Eur. J. Epidemiol.14(1), 37–40 (1998).
   PubMed Web of Science ®Google Scholar
• Hauksdottir GS, Love A, Sigurdardottir V, Jonsson T. Outbreaks of Mycoplasma pneumoniae infections in Iceland 1987 to 1997: a ten and a half years review. Eur. J. Epidemiol.15(1), 95–96 (1999).
   PubMed Web of Science ®Google Scholar
• Ito I, Ishida T, Osawa M et al. Culturally verified Mycoplasma pneumoniae pneumonia in Japan: a long-term observation from 1979–1999. Epidemiol. Infect.127(2), 365–367 (2001).
   PubMed Web of Science ®Google Scholar
• Hong JY, Nah SY, Nam SG, Choi EW, Park JY, Lee WJ. Occurence of Mycoplasma pneumoniae pneumonia in Seoul, Korea, from 1986–1995. J. Korean Pediatr. Soc.40(6), 607–612 (1997).
   Google Scholar
• Kang KS, Woo HO. Pattern of occurrence of Mycoplasma pneumoniae pneumonia in admitted children; southern central Korea, from 1989 to 2002. J. Korean Pediatr. Soc.46(4), 474–479 (2003).
   Google Scholar
• Foy FM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different population of patients. Clin. Infect. Dis.17(Suppl.), S37–S46 (1993).
   PubMed Web of Science ®Google Scholar
• Dorigo-Zetsma JW, Wilbrink B, van der Nat H, Bartelds AI, Heijnen ML, Dankert J. Results of molecular detection of Mycoplasma pneumoniae among patients with acute respiratory infection and in their household contacts reveals children as human reservoirs. J. Infect. Dis.183(4), 15, 675–678 (2001).
   PubMed Web of Science ®Google Scholar
• Brunner H, Prescott B, Greenberg H, James WD, Horswood RL, Chanock RM. Unexpectedly high frequency of antibody to Mycoplasma pneumoniae in human sera as measured by sensitive techniques. J. Infect. Dis.135(4), 524–530 (1977).
   PubMed Web of Science ®Google Scholar
• Pönkä A, Ukonen P. Age-related prevalence of complement-fixating antibody to Mycoplasma pneumoniae during an 8-year period. J. Clin. Microbiol.17(4), 571–575 (1983).
   PubMed Web of Science ®Google Scholar
• Nir-paz R, Michael-Gayego A, Ron M, Block C. Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection. Clin. Micobiol. Infect.12(7), 685–688 (2006).
   PubMed Web of Science ®Google Scholar
• Principi N, Esposito S, Blasi F, Allegra L; Mowgli study group. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. Clin. Infect. Dis.32(9), 1281–1289 (2001).
   PubMedGoogle Scholar
• Layani-Milon MP, Gras I, Valette M et al. Incidence of upper respiratory tract Mycoplasma pneumoniae infections among outpatients in Rhône-Alpes, France, during five successive winter periods. J. Clin. Microbiol.37(6), 1721–1726 (1999).
   PubMed Web of Science ®Google Scholar
• Koff RS. Clinical manifestations and diagnosis of hepatitis A virus infection. Vaccine10(Suppl. 1), S15–S17 (1992).
   PubMed Web of Science ®Google Scholar
• Lee KY, Lee HS, Hong JH et al. Roxithromycin treatment of scrub typhus (tsutsugamushi disease) in children. Pediatr. Infect. Dis. J.22(2), 130–133 (2003).
   PubMed Web of Science ®Google Scholar
• Li AM, Ng PC. Severe acute respiratory syndrome (SARS) in neonates and children. Arch. Dis. Child. Fetal Neonatal Ed.90(6), F461–F465 (2005).
   PubMed Web of Science ®Google Scholar
• Cherrick I, Karayalcin G, Lanzkowsky P. Transient erythroblastopenia of childhood. Prospective study of fifty patients. Am. J. Pediatr. Hematol. Oncol.16(4), 320–324 (1994).
   PubMedGoogle Scholar
• Bux J, Behrens G, Jaeger G, Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood91(1), 181–186 (1998).
   PubMed Web of Science ®Google Scholar
• Blanchette VS, Carcao M. Childhood acute immune thrombocytopenic purpura: 20 years later. Semin. Thromb. Hemost.29(6), 605–617 (2003).
   PubMed Web of Science ®Google Scholar
• Kilic SS, Tezcan I, Sanal O, Metin A, Ersoy F. Transient hypogammaglobulinemia of infancy: clinical and immunological features of 40 new cases. Pediatr. Int.42(6), 647–650 (2000).
   PubMed Web of Science ®Google Scholar
• Lee KY, Han JW, Lee JS. Kawasaki disease may be a hyperimmune reaction of genetically-susceptible children to variants of normal environmental flora. Med. Hypotheses69(3), 642–651 (2007).
   PubMed Web of Science ®Google Scholar
• Dorigo-Zetsma JW, Verkooyen RP, van Helden HP, van der Nat H, van den Bosch JM. Molecular detection of Mycoplasma pneumoniae in adults with community-acquired pneumonia requiring hospitalization. J. Clin. Microbiol.39(3), 1184–1186 (2001).
   PubMed Web of Science ®Google Scholar
• File TM Jr, Tan JS, Plouffe JF. The role of pathogens: Mycoplasma pneumoniae, Chlamidia pneumoniae, and Legionella pheumophilia in respiratory infection. Infect. Dis. Clin. North Am.12(3), 569–592 (1998).
   PubMed Web of Science ®Google Scholar
• Lee SJ, Lee MG, Jeon MJ, Jung KS, Lee HK, Kishimoto T. Atypical pathogens in adult patients admitted with community-acquired pneumonia in Korea. Jpn. J. Infect. Dis.55(5), 157–159 (2002).
   PubMed Web of Science ®Google Scholar
• Su CJ, Chavoya A, Dallo SF, Baseman JB. Sequence divergency of the cytadhesin gene of Mycoplasma pneumoniae. Infect. Immun.58(8), 2669–2674 (1990).
   PubMed Web of Science ®Google Scholar
• Sasaki T, Kenri T, Okazaki N et al. Epidemiological studies of Mycoplasma pneumoniae infections in Japan based on PCR-restriction fragment length polymorphism of the P1 cytadhesin gene. J. Clin. Microbiol.34(2), 447–449 (1996).
   PubMed Web of Science ®Google Scholar
• Dumke R, Catrein I, Herrmann R, Jacobs E. Preference, adaptation and survival of Mycoplasma pneumoniae subtypes in an animal model. Intern. J. Med. Microbiol.294(2–3), 149–155 (2004).
   PubMedGoogle Scholar
• Matsuoka M, Narita M, Okazaki N et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicob. Agents Chemother.48(12), 4624–4630 (2004).
   PubMed Web of Science ®Google Scholar
• Suzuki S, Yamazaki T, Narita M et al. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicob. Agents Chemother.50(2), 709–712 (2006).
   PubMed Web of Science ®Google Scholar
• Denny FW, Clyde WA Jr, Glezen WP. Mycoplasma pneumonia disease: clinical spectrum, pathophysiology, epidemiology, and control. J. Infect. Dis.123(1), 74–92 (1971).
   PubMed Web of Science ®Google Scholar
• Collier AM. Attachment by mycoplasmas and its role in disease. Rev. Infect. Dis.5(Suppl. 4), S685–S691 (1983).
   Google Scholar
• Dallo SF, Kannan TR, Blaylock MW, Baseman JB. Elongation factor Tu and E1 β subunit of pyruvate dehydrogenase complex act as fibronectin binding protein in Mycoplasma pneumoniae. Mol. Microbiol.46(4), 1041–1051 (2002).
   PubMed Web of Science ®Google Scholar
• Almagor M, Yatziv S, Kahane I. Inhibition of host cell catalase by Mycoplasma pneumoniae: a possible mechanism for cell injury. Infect. Immun.41(1), 251–256 (1983).
   PubMed Web of Science ®Google Scholar
• Kannan TR, Baseman JB. ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinants among bacterial pathogens. Proc. Natl Acad. Sci. USA103(17), 6724–6729 (2006).
   PubMed Web of Science ®Google Scholar
• Ohtani N, Miyata M. Identification of a novel nucleoside triphosphate from mycoplasma mobile: a prime candidate motor for gliding motility. Biochem. J.403(1), 71–77 (2007).
   PubMed Web of Science ®Google Scholar
• Totapally BR, Walsh WT. Pneumococcal bacteremia in childhood: a 6-year experience in a community hospital. Chest113(5), 1207–1214 (1998).
   PubMed Web of Science ®Google Scholar
• Dallaire F, Ouellet N, Bergeron T et al. Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia. J. Infect. Dis.184(3), 292–300 (2001).
   PubMed Web of Science ®Google Scholar
• Smith MW, Schmidt JE, Rehg JE, Orihuela CJ, McCullers JA. Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza. Comp. Med.57(1), 82–89 (2007).
   PubMed Web of Science ®Google Scholar
• Rahman SM, Eto H, Morshed SA, Itakura H. Giant cell pneumonia: light microscopy, immunohistochemical, and ultrastructural study of an autopsy case. Utrastruct. Pathol.20(6), 585–591 (1996).
   PubMed Web of Science ®Google Scholar
• Tse GM, To KF, Chan PK et al. Pulmonary pathological features in corona virus associated severe acute respiratory syndrome (SARS). J. Clin. Pathol.57(3), 260–265 (2004).
   PubMed Web of Science ®Google Scholar
• Griffin DE, Ward BJ, Esolen LM. Pathogenesis of measles virus infection: a hypothesis for altered immune responses. J. Infect. Dis.170(Suppl. 1), S24–S31 (1994).
   PubMedGoogle Scholar
• Kaplan LJ, Daum RS, Smaron M, McCarthy CA. Severe measles in immunocompromised patients. JAMA267(9), 1237–1241 (1992).
   PubMed Web of Science ®Google Scholar
• Narita M, Tanaka H, Abe S, Yamada S, Kubota M, Togashi T. Close association between pulmonary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin-18 in the lung, independent of γ interferon. Clin. Diagn. Lab. Immunol.7(6), 909–914 (2000).
   PubMedGoogle Scholar
• Yang J, Hooper WC, Phillips DJ, Talkington DF. Cytokines in Mycoplasma pneumoniae infections. Cytokine Growth Factor Rev.15(2–3), 157–168 (2004).
   PubMed Web of Science ®Google Scholar
• Hardy RD, Jafri HS, Olsen K, Wordemann M, Hatfield J, Rogers BB. Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae model: a micobiologic, histologic, immunologic, and respiratory plethymographic profile. Infect. Immun.69(6), 3869–3876 (2001).
   PubMed Web of Science ®Google Scholar
• Esposito S, Droghetti R, Bosis S, Claut L, Maechisio P, Principi N. Cytokine secretion in children with acute Mycoplasma pneumoniae infection and wheeze. Pediatr. Pulmonol.34(2), 122–127 (2002).
   PubMed Web of Science ®Google Scholar
• Michelow IC, Katz K, MaCracken GH, Hardy RD. Systemic cytokine profile in children with community-acquired pneumonia. Pediatr. Pulmonol.42(7), 640–645 (2007).
   PubMed Web of Science ®Google Scholar
• Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspective in innate immunity. Science284(5428), 1313–1318 (1999).
   PubMed Web of Science ®Google Scholar
• Takeda K, Akira S. Toll-like receptors in innate immunity. Int. Immunol.17(1), 1–14 (2005).
   PubMed Web of Science ®Google Scholar
• Mühlradt PF, Kiess M, Meyer H, Süssmuth R, Jung G. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from mycoplasma ferentance acting at picomolar concentration. J. Exp. Med.185(11), 1951–1958 (1997).
   PubMed Web of Science ®Google Scholar
• Shimizu T, Kida Y, Kuwano K. A dipalmitoylated lipoprotein from Mycoplasma pneumoniae activates NF-k B through TLR1, TLR2, and TLR 6. J. Immunol.175(7), 4641–4646 (2005).
   PubMed Web of Science ®Google Scholar
• Biberfeld G, Sterner G. Effect of Mycoplasma pneumoniae infection on cell-mediated immunity. Infection4(Suppl. 1), 17–20 (1976).
   PubMedGoogle Scholar
• Sabato AR, Cooper DM, Thong YH. Transitory depression of immune function following Mycoplasma pneumoniae infection in children. Pediatr. Res.15(5), 813–816 (1981).
   PubMed Web of Science ®Google Scholar
• Tanaka H, Koba H, Honma S, Sugaye F, Abe S. Relationships between radiological pattern and cell mediated immune response in Mycoplasma pneumoniae pneumonia. Eur. Respir. J.9(4), 669–672 (1996).
   PubMed Web of Science ®Google Scholar
• Nahm CH, Cho EY, Lee KY, Kang JH, Lee BC. A comparative study of Mycoplasma pneumoniae pneumonia according to age. J. Korean Pediatr. Infect. Dis.12(1), 135–139 (2005).
   Google Scholar
• Lee KY, Lee HS, Hur JK et al. Clinical features of measles according to age in a measles epidemic. Scand. J. Infect. Dis.37(6–7), 471–475 (2005).
   PubMed Web of Science ®Google Scholar
• Starr S, Berkovich S. Effects of measles, γ-globulin-modified measles and vaccine measles on the tuberculin test. N. Engl. J. Med.270 (7), 386–391 (1964).
   PubMed Web of Science ®Google Scholar
• Peiris JS, Chu CM, Cheng VC et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet361(9371), 1767–1772 (2003).
   PubMed Web of Science ®Google Scholar
• Noriega ER, Simberkoff MS, Gilroy FJ, Rahal JJ. Life-threatening Mycoplasma pneumoniae pneumonia. JAMA229(11), 1471–1472 (1974).
   PubMed Web of Science ®Google Scholar
• Holt S, Ryan WF, Epstein EJ. Severe mycoplasma pneumonia. Thorax32(1), 112–115 (1977).
   PubMed Web of Science ®Google Scholar
• Radisic M, Torn A, Gutierrez P, Defranchi HA, Pardo P. Severe acute lung injury caused by Mycoplasma pneumoniae: potential role for steroid pulses in treatment. Clin. Infect. Dis.31(6), 1507–1511 (2000).
   PubMed Web of Science ®Google Scholar
• Klement E, Talkington DF, Wasserzug O et al. Identification of risk factors for infection in an outbreak of Mycoplasma pneumoniae respitatory tract disease Clin. Infect. Dis.43(10), 1239–1245 (2006).
   Web of Science ®Google Scholar
• Denny FW, Taylor-Robinson D, Allison C. The role of thymus-dependent immunity in Mycoplasma pulmonis infection of mice. J. Med. Microbiol.5(3), 327–336 (1972).
   PubMed Web of Science ®Google Scholar
• Taylor G. Immunity to mycoplasma infections of the respiratory tract: a review. J. Royal. Soc. Med.72(7), 520–526 (1979).
   PubMed Web of Science ®Google Scholar
• Tanaka H, Honma S, Abe S, Tamura H. Effects of IL-2 and cyclosporin A on pathologic features in mycoplasma pneumonia. Am. J. Respir. Crit. Care Med.154(6), 1908–1912 (1996).
   PubMed Web of Science ®Google Scholar
• Jacobs E, Stuhlert A, Drews M et al. Host reactions to Mycoplasma pneumoniae infections in guinea-pigs preimmunised systemically with the adhesion of this pathogen. Microb. Pathog.5(4), 259–265 (1988).
   PubMed Web of Science ®Google Scholar
• Cimolai N, Cheong ACH, Morrison BJ, Taylor GP. Protective and harmful immunoreactivity after Mycoplasma pneumoniae reinfection and vaccination. Vaccine14(15), 1479–1483 (1996).
   PubMed Web of Science ®Google Scholar
• Dajani AS, Clyde WA Jr, Denny FW. Experimental infection with Mycoplasma pneumoniae (Eaton’s agent). J. Exp. Med.121(5), 1071–1087 (1965).
   PubMed Web of Science ®Google Scholar
• Opitz O, Pietsch K, Ehlers, Jacobs E. Cytokine gene expression in immune mice reinfected with Mycoplasma pneumoniae: the role of T cell subsets in aggravating the inflammatory response.Immunobiology196(5), 575–587 (1996–1997).
   PubMed Web of Science ®Google Scholar
• Llibre JM, Urban A, Garcia E, Carrasco MA, Murcia C. Bronchiolotis obliterance organizing pneumonia associated with acute Mycoplasma pneumoniae infection. Clin. Infect. Dis.25(6), 1340–1342 (1997).
   PubMed Web of Science ®Google Scholar
• Rollins S, Colby T, Clayton F. Open lung biopsy in Mycoplasma pneumoniae pneumonia. Arch. Pathol. Lab. Med.110(1), 34–41 (1986).
   PubMed Web of Science ®Google Scholar
• Vuori-Holopainen E, Salo E, Saxen H et al. Etiologic diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods. Clin. Infect. Dis.34(3), 583–590 (2002).
   PubMed Web of Science ®Google Scholar
• Cimolai N. Corticosteroids and complicated Mycoplasma pneumoniae infection. Pediatr. Pulmonol.41(10), 1008–1009 (2006).
   PubMed Web of Science ®Google Scholar
• Tai DY. Pharmacologic treatment of SARS: current knowledge and recommendations. Ann. Acad. Med. Singap.36(6), 438–443 (2007).
   PubMed Web of Science ®Google Scholar
• Carter MJ. A rationale for using steroids in the treatment of severe cases of H5N1 avian influenza. J. Med. Microbiol.56(Pt 7), 875–883 (2007).
   PubMed Web of Science ®Google Scholar
• Gnarpe J, Lundbäck A, Sundelöf B, Gnarpe H. Prevalence of Mycoplasma pneumoniae in subjectively healthy individuals. Scand. J. Infect. Dis.24(2), 161–164 (1992).
   PubMed Web of Science ®Google Scholar
• Buchwald DS, Blaser MJ. A review of human salmonellosis: II. Duration of excretion following infection with nontyphi Salmonella. Rev. Infect. Dis.6(3), 345–356 (1984).
   PubMedGoogle Scholar
• Glebe D. Recent advances in hepatitis B virus research: a German point of view. World J. Gastroenterol.13(1), 8–13 (2007).
   PubMed Web of Science ®Google Scholar
• Samore MH, Magill MK, Alder SC et al. High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: association with cephalosporin use and intrafamilial transmission. Pediatrics108(4), 856–865 (2001).
   PubMed Web of Science ®Google Scholar
• Jain A, Kumar P, Awasthi S. High nasopharyngeal carriage of drug resistant Streptococcus pneumoniae and Haemophilus influenzae in north Indian schoolchildren. Trop. Med. Int. Health10(3), 234–249 (2005).
   PubMed Web of Science ®Google Scholar
• McIntosh K. Pathogenesis of severe acute respiratory infections in the developing world: respiratory syncitial viruses and parainfluenza viruses. Rev. Infect. Dis.13(Suppl. 6), S492–S500 (1991).
   PubMedGoogle Scholar
• Foy HM, Kenny GE, McMahan R, Mansy AM. Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. JAMA214(9), 1666–1672 (1970).
   PubMed Web of Science ®Google Scholar
• Mundy LM, Oldach D, Auwaerter PG et al. Implication for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team. Chest113(5), 1201–1206 (1998).
   PubMed Web of Science ®Google Scholar
• Shefet D, Robenshotock E, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults. Cochrane Database Syst. Rev.18(2), CD004418 (2005).
   Google Scholar
• Marc E, Chaussain M, Moulin F et al. Reducing lung diffusion capacity after Mycoplasma pneumoniae pneumonia. Pediatr. Infect. Dis. J.19(8), 706–710 (2000).
   PubMed Web of Science ®Google Scholar
• Nisar N, Guleria R, Kumar S, Chand-Chawla T, Ranjan Biswas N. Mycoplasma pneumoniae and its role in asthma. Postgrad. Med. J.83(976), 100–104 (2007).
   PubMed Web of Science ®Google Scholar
• Neumayr L, Lennette E, Kelly D et al. Mycoplasma disease and acute chest syndrome in sickle cell disease. Pediatrics112(1), 87–97 (2003).
   PubMed Web of Science ®Google Scholar
• Fernald GW. Immunologic mechanisms suggested in the association of M. pneumoniae infection and extrapulmonary disease: a review. Yale J. Biol. Med.56(5–6), 475–479 (1983).
   PubMed Web of Science ®Google Scholar
• Tsiodras S, Kelesidis I, Kelsidis T, Stamboulis E, Giamarellou H. Central nervous system manifestations of Mycoplasma pneumoniae infections. J. Infect.51(5), 343–354 (2005).
   PubMed Web of Science ®Google Scholar
• Christie LJ, Honarmand S, Talkington DF et al. Pediatric encephalitis: what is the role of Mycoplasma pneumoniae? Pediatrics120(2), 305–313 (2007).
   PubMed Web of Science ®Google Scholar
• John SD, Ramanathan J, Swischuk LE. Spectrum of clinical and radiographic findings in pediatric mycoplasma pneumonia. Radiographics21(1), 121–131 (2001).
   PubMed Web of Science ®Google Scholar
• Osborne D. Radiologic appearance of viral disease of the lower respiratory tract in infant and children. Am. J. Radiol.130(1), 29–33 (1978).
   Google Scholar
• Wildin SR, Chonmaitree T, Swischuk LE. Roentgenographic features of common pediatric viral respiratory tract infections. Am. J. Dis. Child.142(1), 43–46 (1988).
   PubMedGoogle Scholar
• Kim EA, Lee KS, Primack SL et al. Viral pneumonias in adults: radiologic and pathologic findings. Radiographics22(Spec. issue), S137–S149 (2002).
   PubMed Web of Science ®Google Scholar
• Nambu A, Saito A, Araki T et al.Chlamydia pneumoniae: comparison with findings of Mycoplasma pneumoniae and Streptococcus pneumonia at thin-section CT. Radiology238(1), 330–338 (2006).
   PubMed Web of Science ®Google Scholar
• George RB, Weill H, Rasch JR, Mogabgab WJ, Ziskind MM. Roentgenographic appearance of viral and mycoplasmal pneumonias. Am. Rev. Resp. Dis.96(6), 1144–1150 (1967).
   PubMed Web of Science ®Google Scholar
• Korppi M, Don M, Valent F, Canciani M. The value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children. Acta Paediatr.97(7), 943–947 (2008).
   PubMed Web of Science ®Google Scholar
• Shon JW, Park SC, Choi YH et al. Atypical pathogens as etiologic agents in hospitalized patients with community-acquired pneumonia in Korea: a prospective multi-center study. J. Korean. Med. Sci.21(4), 602–607 (2006).
   PubMed Web of Science ®Google Scholar
• Clyne B, Olshaker JS. The C-reactive protein. J. Emerg. Med.17(6), 1019–1025 (1999).
   PubMed Web of Science ®Google Scholar
• Petitjean J, Vabret A, Gouarin S, Freymuth F. Evaluation of four commercial immunoglobulin G (IgG)-and IgM-specific enzyme immunoassays for diagnosis of Mycoplasma pneumoniae infections. J. Clin. Microbiol.40(1), 167–171 (2002).
   Google Scholar
• Beersma MF, Dirven K, van Dam AP, Templeton KE, Claas ECJ, Goossens H. Evaluation of 12 commercial tests and the complementary fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the “gold standard” J. Clin. Microbiol.43(5), 2277–2285 (2005).
   PubMed Web of Science ®Google Scholar
• Lee KY, Lee HS, Hur JK, Kang JH, Lee BC. The changing epidemiology of hospitalized pediatric patients in three measles outbreaks. J. Infect.54(2), 167–172 (2007).
   PubMed Web of Science ®Google Scholar
• Pruzanski W, Katz A. Cold agglutinins: antibodies with biological diversity. Clin. Immunol. Rev.3(1), 131–168 (1984).
   PubMedGoogle Scholar
• Griffin JP. Rapid screening for cold agglutinins in pneumonia. Ann. Intern. Med.70(4), 701–705 (1969).
   PubMed Web of Science ®Google Scholar
• Ngiam TE, Yap HK, Low PS et al. A rapid screening test in Mycoplasma pneumoniae infection. J. Singapore Pediatr. Soc.22(1–4), 81–83 (1980).
   PubMedGoogle Scholar
• Shankar EM, Kumarasamy N, Balakrishnan P et al. Seroprevalence of acute Mycoplasma pneumoniae infection HIV infected patients with pulmonary complaints in Chennai, southern India. J. Infect.53(5), 325–330 (2006).
   PubMed Web of Science ®Google Scholar
• Moon SN, Lee MH, Lee KY, Lee JS. The diagnostic antibodies and polymerase chain reaction in Mycoplasma pneumoniae pneumonia. Presented at: The 57th Annual Fall Meeting of the Korean Pediatric Society, Seoul, Korea, 19–20 October, 2007 (Abstract 241).
   Google Scholar
• Waits KB, Thacker WL, Talkington DF. The value of culture and serology for detection of Mycoplasma pneumoniae infections in the clinical laboratory in the age of molecular diagnostics. Clin. Microbiol. Newslett.23(1), 123–129 (2001).
   Google Scholar
• Loens K, Ursi D, Goossens H, Leven M. Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections. J. Clin. Microbiol.41(11) 4915–4923 (2003).
   PubMed Web of Science ®Google Scholar
• Daxboeck F, Krause R, Weinsch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin. Microbiol. Infect.9(4), 263–273 (2003).
   PubMed Web of Science ®Google Scholar
• Bernet C, Garret M, de Barbeyrac B, Bebear C, Bonnet J. Detection of Mycoplasma pneumoniae by using the polymerase chain reaction. J. Clin. Microbiol.27(11), 2492–2496 (1989).
   PubMed Web of Science ®Google Scholar
• Nadal D, Bossart W, Zucol F et al. Community-acquired pneumonia in children due to Mycoplasma pneumoniae: diagnostic performance of a seminested 16S rDNA-PCR. Diagn. Microbial. Infect. Dis.39(1), 15–19 (2001).
   PubMed Web of Science ®Google Scholar
• Morozumi M, Ito A, Murayama SY et al. Assessment of real-time PCR for diagnosis of Mycoplasma pneumoniae pneumonia in pediatric patients. Can. J. Microbiol.52(2) 125–129 (2006).
   PubMed Web of Science ®Google Scholar
• Weigl JA, Puppe B, Gröndahl B, Schimitt HJ. Epidemiological investigation of nine respiratory pathogens in hospitalized children in Germany using multiplex reverse-transcriptase polymerase chain reaction. Eur. J. Clin. Microbiol. Infect. Dis.19(5), 336–343 (2000).
   PubMed Web of Science ®Google Scholar
• Räty R, Rönkkö E, Kleemola M. Sample type is crucial to the diagnosis of Mycoplasma pneumoniae pneumonia by PCR. J. Med. Microbiol.54(3), 287–291 (2005).
   PubMed Web of Science ®Google Scholar
• Kingston JR, Chanock RM, Musfun MA. Eaton agent pneumonia. JAMA176(4), 118–123 (1961).
   PubMed Web of Science ®Google Scholar
• Rasch JR, Mogabgab WJ. Therapeutic effect of erythromycin on Mycoplasma pneumoniae pneumonia. Anthmicrob. Agents Chemother.5, 633–639 (1965).
   Google Scholar
• McCracken GH Jr. Current status of antibiotic treatment for Mycoplasma pneumoniae infections. Pediatr. Infect. Dis.5(1), 167–171 (1986).
   PubMedGoogle Scholar
• Manfredi R, Januzzi C, Mantero E et al. Clinical comparative studiy of azithromycin versus erythromycin in the treatment of acute respiratory tract infections in children. J. Chemother.4(6), 364–370 (1992).
   PubMed Web of Science ®Google Scholar
• Block S, Hedrick J, Hammerschlag MR, Cassell GH, Craft JC. Mycoplasma pneumoniae and Chlamidia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr. Infect. Dis. J.14(6), 471–477 (1995).
   PubMed Web of Science ®Google Scholar
• Hardy RD, Rios AN, Chaver-Bueno S et al. Antimicrobial and immunologic activities of charithromycin in a murine model of Mycoplasma pneumoniae-induced pneumonia. Antimicrob. Agents Chemother.47(5), 1614–1620 (2003).
   PubMed Web of Science ®Google Scholar
• File TM Jr, Segreti J, Dunber L et al. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxim axetil in treatment of adults with community-acquired pneumonia. Antimicrob. Agents Chemother.41(9), 1965–1972 (1997).
   PubMed Web of Science ®Google Scholar
• Gavranich JB, Chang AB. Antibiotics for community acquired lower respiratory tract infections (LRTI) secondary to Mycoplasma pneumoniae in children. Cochrane Database Sys. Rev.20(3), CD004875 (2005).
   Google Scholar
• Wubbel L, Muniz L, Ahmed A et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr. Infect. Dis. J.18(2), 98–104 (1999).
   PubMed Web of Science ®Google Scholar
• Harris JA, Kolokathis A, Cambell M, Cassel GH, Hammerschulag MR. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. Pediatr. Infect. Dis. J.17(10), 865–871 (1998).
   PubMed Web of Science ®Google Scholar
• Othman N, Isaacs, Kesson A. Mycoplasma pneumoniae infections in Australian children. J. Paediatr. Child Health41, 671–676 (2005).
   PubMed Web of Science ®Google Scholar
• Daxboeck F, Eisl B, Burghuber C, Memarsadeghi M, Assadian O, Stneck G. Fetal Mycoplasma pneumoniae pneumonia in a previously healthy 18-year-old girl. Wien. Klin. Wochenschr.119(6), 379–384 (2007).
   PubMed Web of Science ®Google Scholar
• McGowan JE Jr, Chesney PJ, Crossley KB, LaForce FM. Guidelines for the use of systemic glucocorticosteroids in the management of selected infections. J. Infect. Dis.165(1), 1–13 (1992).
   PubMed Web of Science ®Google Scholar
• Sibéril S, Elluru S, Negi VS et al. Intravenous immunoglobulin in autoimmune and inflammatory disease: more than mere transfer of antibodies. Transfus. Apher. Sci.37(1), 102–107 (2007).
   Google Scholar
• Lee KY, Lee JS. Immunoglobulin G has a role for systemic protein modulation in vivo: a new concept of protein homeostasis. Med. Hypotheses67(4), 848–855 (2006).
   PubMed Web of Science ®Google Scholar
• Wang JL, Ho MY, Shen EY. Mycoplasma pneumoniae infection associated with hemolytic anemia: report of one case. Acta Paediatr. Taiwan45(5), 293–295 (2004).
   PubMedGoogle Scholar
• Steer AC, Starr M, Kornberg AJ. Bickerstaff brainstem encephalitis associated with Mycoplasma pneumoniae infection. J. Child Neurol.21(6), 544–534 (2006).
   PubMed Web of Science ®Google Scholar
• Bream-Rouwenhorst HR, Beltz EA, Ross MB, Moores KG. Recent developments in the management of acute respiratory distress syndrome in adults. Am. J. Health Syst. Pharm.65(1), 29–36 (1998).
   Google Scholar
• Kim CK, Chung CY, Kim JS, Kim WS, Park Y, Koh YY. Late abnormal findings on high-resolution computed tomography after mycoplasma pneumonia. Pediatrics105(2), 372–378 (2000).
   PubMed Web of Science ®Google Scholar
• Stokes D, Sigler A, Khouri NF, Talamo RC. Unilateral hyperlucent lung (Swyer–James syndrome) after severe Mycoplasma pneumoniae infection. Am. Rev. Respir. Dis.117(1), 145–152 (1978).
   PubMedGoogle Scholar